Invasive pulmonary aspergillosis presenting with tracheopleural fistula in a pediatric patient with a history of rhabdomyosarcoma

por Khatun, Munteha, Julson, Janet, Taylor, David W., Foxworthy, Blake O., Beierle, Elizabeth A., Aye, Jamie M.
Publicado 2023

PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells

por Stafman, Laura L., Williams, Adele P., Marayati, Raoud, Aye, Jamie M., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Publicado 2019

Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth

por Williams, Adele P., Garner, Evan F., Waters, Alicia M., Stafman, Laura L., Aye, Jamie M., Markert, Hooper, Stewart, Jerry E., Beierle, Elizabeth A.
Publicado 2018

Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma()()

por Stafman, Laura L., Williams, Adele P., Garner, Evan F., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Whelan, Kimberly, Beierle, Elizabeth A.
Publicado 2018

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

por Garner, Evan F., Williams, Adele P., Stafman, Laura L., Aye, Jamie M., Mroczek-Musulman, Elizabeth, Moore, Blake P., Stewart, Jerry E., Friedman, Gregory K., Beierle, Elizabeth A.
Publicado 2018

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma

por Stafman, Laura L., Mruthyunjayappa, Smitha, Waters, Alicia M., Garner, Evan F., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Whelan, Kimberly, Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Publicado 2018

9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts

por Marayati, Raoud, Bownes, Laura V., Stafman, Laura L., Williams, Adele P., Quinn, Colin H., Atigadda, Venkatram, Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Beierle, Elizabeth A.
Publicado 2020

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma

por Marayati, Raoud, Stafman, Laura L., Williams, Adele P., Bownes, Laura V., Quinn, Colin H., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Anderson, Joshua C., Willey, Christopher D., Beierle, Elizabeth A.
Publicado 2021

EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth

por Bownes, Laura V., Williams, Adele P., Marayati, Raoud, Stafman, Laura L., Markert, Hooper, Quinn, Colin H., Wadhwani, Nikita, Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Publicado 2021

Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts

por Stafman, Laura L., Williams, Adele P., Marayati, Raoud, Aye, Jamie M., Markert, Hooper R., Garner, Evan F., Quinn, Colin H., Lallani, Shoeb B., Stewart, Jerry E., Yoon, Karina J., Whelan, Kimberly, Beierle, Elizabeth A.
Publicado 2019

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts

por Williams, Adele P., Garner, Evan F., Stafman, Laura L., Aye, Jamie M., Quinn, Colin H., Marayati, Raoud, Stewart, Jerry E., Atigadda, Venkatram R., Mroczek-Musulman, Elizabeth, Moore, Blake P., Beierle, Elizabeth A., Friedman, Gregory K.
Publicado 2019

Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor

por Quinn, Colin H., Beierle, Andee M., Williams, Adele P., Marayati, Raoud, Bownes, Laura V., Markert, Hooper R., Aye, Jamie M., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Crossman, David K., Yoon, Karina J., Beierle, Elizabeth A.
Publicado 2021

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma

por Bownes, Laura V., Marayati, Raoud, Quinn, Colin H., Beierle, Andee M., Hutchins, Sara C., Julson, Janet R., Erwin, Michael H., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Ohlmeyer, Michael, Aye, Jamie M., Yoon, Karina J., Beierle, Elizabeth A.
Publicado 2022

Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy

por Quinn, Colin H., Beierle, Andee M., Hutchins, Sara Claire, Marayati, Raoud, Bownes, Laura V., Stewart, Jerry E., Markert, Hooper R., Erwin, Michael H., Aye, Jamie M., Yoon, Karina J., Friedman, Gregory K., Willey, Christopher D., Markert, James M., Beierle, Elizabeth A.
Publicado 2022

Using 3D-bioprinted models to study pediatric neural crest-derived tumors

por Quinn, Colin H, Beierle, Andee M, Julson, Janet R, Erwin, Michael E, Alrefai, Hasan, Markert, Hooper R, Stewart, Jerry E, Hutchins, Sara Claire, Bownes, Laura V, Aye, Jamie M, Mroczek-Musulman, Elizabeth, Hicks, Patricia H, Yoon, Karina J, Willey, Christopher D, Beierle1, Elizabeth A
Publicado 2023

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor

por Aye, Jamie M., Stafman, Laura L., Williams, Adele P., Garner, Evan F., Stewart, Jerry E., Anderson, Joshua C., Mruthyunjayappa, Smitha, Waldrop, Mary G., Goolsby, Caroline D., Markert, Hooper R., Quinn, Colin, Marayati, Raoud, Mroczek-Musulman, Elizabeth, Willey, Christopher D., Yoon, Karina J., Whelan, Kimberly F., Beierle, Elizabeth A.
Publicado 2019